- call +1-201-465-4211
- email sales@mrinsights.biz
According to Mendel's Laws, the monogenetic disorders are inherited because of a single defective gene on the autosomes. The monogenic disorders are caused by single mutated gene which can be present on single or both chromosomes. Females and males are equally affected by this disorder due to the conditions on the autosomes. Some of the tests are available for the mainstream of the common monogenic disorders such as Cystic fibrosis, sickle cell anemia, SCID, Tay-sachs disease, polycystic kidney disorder, Gaucher's disease, Huntington's disease, neurofibromatosis, thalassaemia and familial hypercholesterolemia. There are several test performed to treat with the monogenic disorders such as diagnostic testing, carrier testing, predictive & pre-symptomatic testing, prenatal testing and new-born screening.
Scope of the Report:
This report studies the Monogenetic Disorders Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Monogenetic Disorders Testing market by product type and applications/end industries.
North America clearly dominates the global monogenetic disorders testing market due to high degree of intelligence and awareness regarding to the monogenic disorders testing procedures. The companies are focused on introducing the procedures with innovative technology, Europe is expected to hold the second large market followed by Asia-Pacific region.
The global Monogenetic Disorders Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Monogenetic Disorders Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Celera Group
Abbott
Thermo Fisher Scientific
ELITech Group
Quest
AutoGenomics
PerkinElmer
Roche
Bio-Rad
Transgenomic
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Others
Market Segment by Applications, can be divided into
Hospitals
Specialized Clinics
Ambulatory Surgical Centers
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Monogenetic Disorders Testing Market Overview
1.1 Product Overview and Scope of Monogenetic Disorders Testing
1.2 Classification of Monogenetic Disorders Testing by Types
1.2.1 Global Monogenetic Disorders Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Monogenetic Disorders Testing Revenue Market Share by Types in 2017
1.2.3 Carrier Testing
1.2.4 Diagnostic Testing
1.2.5 New-Born Screening
1.2.6 Predictive & Pre-Symptomatic Testing
1.2.7 Prenatal Testing
1.2.8 Others
1.3 Global Monogenetic Disorders Testing Market by Application
1.3.1 Global Monogenetic Disorders Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Specialized Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Global Monogenetic Disorders Testing Market by Regions
1.4.1 Global Monogenetic Disorders Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Monogenetic Disorders Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Monogenetic Disorders Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Monogenetic Disorders Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Monogenetic Disorders Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Monogenetic Disorders Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Monogenetic Disorders Testing (2013-2023)
2 Manufacturers Profiles
2.1 Celera Group
2.1.1 Business Overview
2.1.2 Monogenetic Disorders Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Celera Group Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott
2.2.1 Business Overview
2.2.2 Monogenetic Disorders Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Thermo Fisher Scientific
2.3.1 Business Overview
2.3.2 Monogenetic Disorders Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Thermo Fisher Scientific Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 ELITech Group
2.4.1 Business Overview
2.4.2 Monogenetic Disorders Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 ELITech Group Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Quest
2.5.1 Business Overview
2.5.2 Monogenetic Disorders Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Quest Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 AutoGenomics
2.6.1 Business Overview
2.6.2 Monogenetic Disorders Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 AutoGenomics Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 PerkinElmer
2.7.1 Business Overview
2.7.2 Monogenetic Disorders Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 PerkinElmer Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Roche
2.8.1 Business Overview
2.8.2 Monogenetic Disorders Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Roche Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bio-Rad
2.9.1 Business Overview
2.9.2 Monogenetic Disorders Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bio-Rad Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Transgenomic
2.10.1 Business Overview
2.10.2 Monogenetic Disorders Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Transgenomic Monogenetic Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Monogenetic Disorders Testing Market Competition, by Players
3.1 Global Monogenetic Disorders Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Monogenetic Disorders Testing Players Market Share
3.2.2 Top 10 Monogenetic Disorders Testing Players Market Share
3.3 Market Competition Trend
4 Global Monogenetic Disorders Testing Market Size by Regions
4.1 Global Monogenetic Disorders Testing Revenue and Market Share by Regions
4.2 North America Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
4.5 South America Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
5 North America Monogenetic Disorders Testing Revenue by Countries
5.1 North America Monogenetic Disorders Testing Revenue by Countries (2013-2018)
5.2 USA Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
6 Europe Monogenetic Disorders Testing Revenue by Countries
6.1 Europe Monogenetic Disorders Testing Revenue by Countries (2013-2018)
6.2 Germany Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
6.3 UK Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
6.4 France Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Monogenetic Disorders Testing Revenue by Countries
7.1 Asia-Pacific Monogenetic Disorders Testing Revenue by Countries (2013-2018)
7.2 China Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
7.5 India Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
8 South America Monogenetic Disorders Testing Revenue by Countries
8.1 South America Monogenetic Disorders Testing Revenue by Countries (2013-2018)
8.2 Brazil Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Monogenetic Disorders Testing by Countries
9.1 Middle East and Africa Monogenetic Disorders Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Monogenetic Disorders Testing Revenue and Growth Rate (2013-2018)
10 Global Monogenetic Disorders Testing Market Segment by Type
10.1 Global Monogenetic Disorders Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Monogenetic Disorders Testing Market Forecast by Type (2018-2023)
10.3 Carrier Testing Revenue Growth Rate (2013-2023)
10.4 Diagnostic Testing Revenue Growth Rate (2013-2023)
10.5 New-Born Screening Revenue Growth Rate (2013-2023)
10.6 Predictive & Pre-Symptomatic Testing Revenue Growth Rate (2013-2023)
10.7 Prenatal Testing Revenue Growth Rate (2013-2023)
10.8 Others Revenue Growth Rate (2013-2023)
11 Global Monogenetic Disorders Testing Market Segment by Application
11.1 Global Monogenetic Disorders Testing Revenue Market Share by Application (2013-2018)
11.2 Monogenetic Disorders Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Specialized Clinics Revenue Growth (2013-2018)
11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)
12 Global Monogenetic Disorders Testing Market Size Forecast (2018-2023)
12.1 Global Monogenetic Disorders Testing Market Size Forecast (2018-2023)
12.2 Global Monogenetic Disorders Testing Market Forecast by Regions (2018-2023)
12.3 North America Monogenetic Disorders Testing Revenue Market Forecast (2018-2023)
12.4 Europe Monogenetic Disorders Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Monogenetic Disorders Testing Revenue Market Forecast (2018-2023)
12.6 South America Monogenetic Disorders Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Monogenetic Disorders Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Monogenetic Disorders Testing Picture
Table Product Specifications of Monogenetic Disorders Testing
Table Global Monogenetic Disorders Testing and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
